The biotech stock's price-to-earnings-to-growth (PEG) ratio is a super-low 0.58, according to the London Stock Exchange Group (LSEG). Any PEG ratio below 1.0 is viewed as an attractive valuation.

Vertex Pharmaceuticals (NASDAQ: VRTX) hasn't witnessed the crazy price spike that some other stocks have had in the new bull ...

A bid to build six homes in a popular north Norfolk holiday village has been denied. The plans were submitted in June and included details to build six homes in Stiffkey on half- of a hectare of land.

A recent Commercial Observer gathered the experts and asked them about sustainability regulations impacting health care ...

I decided to replace my i9-9900K / 2080 Ti build with an i7-13700K / 3080 FE build. While I was overall happy with the build, ...

Sometimes, complex technical achievements are best explained through one example. That's the approach Mete Atamel, Developer ...

Keith Speights has positions in Pfizer and Vertex Pharmaceuticals. The Motley Fool has positions in and recommends Merck, Pfizer, and Vertex Pharmaceuticals. The Motley Fool recommends Moderna. The ...

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, ...